Tubeless Insulin Pump Market by Component (Pod/Patch, Remote, Others), By Distribution Channel (Pharmacies, e-Commerce, Hospitals, Others), Regional Outlook (North America, Europe, Asia-Pacific, LAMEA), Global Opportunity Analysis and Industry Forecast, 2019-2026

Tubeless Insulin Pump Market Growth 2026:

Global tubeless insulin pump market growth is projected to a CAGR of 23.4% generating a revenue of $ 2,837.6 million by 2026.

A tubeless insulin pump is a convenient, effective and portable device that aids in controlling the blood glucose level of the user. The tubeless insulin pump market is estimated to have significant growth in the forecast period. Increasing diabetic cases, especially among geriatric patients, will accelerate the acceptance of tubeless insulin pumps, as they take better care of the patients and control the disease consequences.

Tubeless Insulin Pump Market Drivers:

Rising diabetic cases and the technological advancements in the tubeless insulin pump market is anticipated to boost the growth of tubeless insulin pump market

The key factor driving the growth of the tubeless insulin pump market is the growing number of diabetic cases. The diabetes is found not only in geriatric population, but also in children and mid-aged population. According to the World Health Organization (WHO), around 1.6 million deaths occurred in 2016, due to diabetes. The market is further anticipated to grow owing to the technological advancements in the tubeless insulin pump market, such as the incorporation of smart technologies in insulin pods and remotes. Traditional invasive insulin pumps cause injuries and infections to patients. Due to this, the patients are preferring the tubeless insulin pumps, which are not harmful to the patient’s body. Moreover, increasing government initiatives to raise awareness globally about diabetes management and Medicare policies are set to boost the overall market growth during the projected period.

Market Restraints:

The high cost of the tubeless insulin pump and increased risk of diabetic ketoacidosis are some of the major threats for the growth of tubeless insulin pump market

The high cost of the tubeless insulin pumps acts as a significant threat to the growth of the tubeless insulin pump market. Also, there are high chances of getting diabetic ketoacidosis for the user, in case of pump failures. This can happen in case of battery drainage, insulin inactivation by heat exposure, or in the presence of a dry tank. In these cases, insulin spills or the catheter becomes kinked to avoid the delivery. Due to this, the patient has to face a lot of consequences including skin diseases.

Tubeless Insulin Pump Market Segment, by Component:

The pods' segment is predicted to be most profitable till the end of 2026

Source: Research Dive Analysis

The market size for pods was $311.4 million in 2018 and is expected to grow at a CAGR of 23.6% during the anticipated period. The pod is a lightweight, disposable vessel that can be attached anywhere on the user’s body and can be carried up to three days of nonstop insulin, wherein the pod will check the blood sugar level and inject the insulin whenever required. The pods are normally pre-filled with insulin which is inserted by a small, flexible cannula to deliver insulin to the user so that the patient can get use them along with their pods for checking their insulin level. This kit also consists of a pump that can be operated via the phone, with advanced devices such as Bluetooth-enabled devices, wearables, and others.

Tubeless Insulin Pump Market, by Distribution channel

E-commerce segment will possess high investment opportunities in the coming future.

Source: Research Dive Analysis

The Ecommerce distribution channel segment has become one of the most commonly used channels for the sales of tubeless insulin pumps. The revenue generated by the product sales through this channel in 2018 was $279.7 million and is estimated to witness growth at more than 23.5% CAGR till 2026. The consumers are highly attracted to the economic benefits offered by these channels and are preferring over purchases through the traditional offline channels.

Tubeless Insulin Pump Market, by Region

North America region will have enormous opportunities for the market investors to grow over the coming years

Source: Research Dive Analysis

North America's regional market held the largest tubeless insulin pump market share in 2018. This regional market held the market size of $184.7 million in 2018 and is expected to exceed $924.5 million by 2026, at a CAGR of 22.3%. Due to the lack of physical activity and increase in the number of old age population among the people in this region can be the biggest region for the increase in the diabetic population. U.S. and Canada are predicted to witness a significant increase in the diabetic population over the coming years, which will further drive the market for more investment opportunities in the tubeless insulin pump market during the forecast period.

Key participants and competitive landscape analysis of Global Tubeless insulin pump Market:

Technological enhancement and agreements are the most common strategies followed by the market players

Source: Research Dive Analysis

Some of the tubeless Insulin Pump market players are Medtrum Technologies Inc, Insulet Corporation, Debiotech, Johnson & Johnson, Rosh Holding AG, Cellnovo Group SA, Spring Health Solution Ltd, Veleritas, CeQur SA, and Abbott Diabetes Care among many others. The competitive landscape analysis of tubeless insulin pump market will be analyzed among the above mentioned players.

Recent Developments in Tubeless Insulin Pump Market:

In 2016, a U.S based pharmacy firm Insulet Corporation and another company named Eli Lilly & Company entered into an agreement to build a new model of tubeless Omni pod insulin delivery system to distribute highly concentrated U200 and U500 insulin formulations. Therefore, it is undeniable that collaborations witnessed across the pharmaceutical and healthcare sector that had a significant impact on the overall business.

Scope The Research Report:

Source: Research Dive Analysis

1. Research Methodology

1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters

1.4.1. Assumptions
1.4.2. Forecast parameters

1.5. Data sources

1.5.1. Primary
1.5.2. Secondary

2. Executive Summary

2.1. 360° summary
2.2. Component trends
2.3. Distribution channel trends

3. Market overview

3.1. Market segmentation & definitions
3.2. Key takeaways

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market

3.4. Market dynamics

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Pricing overview

3.8.1. Component
3.8.2. Distribution Channel

3.9. Market value chain analysis

3.9.1. Stress point analysis
3.9.2. Distribution channel analysis
3.9.3. Operating vendors

3.9.3.1. Raw material suppliers
3.9.3.2. Product manufacturers
3.9.3.3. Product distributors

3.10. Strategic overview

4. Tubeless Insulin Pump Market, by Component

4.1. Pod/Patch

4.1.1. Market size and forecast, by region, 2016-2026
4.1.2. Comparative market share analysis, 2018 & 2026

4.2. Remote

4.2.1. Market size and forecast, by region, 2016-2026
4.2.2. Comparative market share analysis, 2018 & 2026

4.3. Others

4.3.1. Market size and forecast, by region, 2016-2026
4.3.2. Comparative market share analysis, 2018 & 2026

5. Tubeless Insulin Pump Market, by Distribution Channel

5.1. Ecommerce

5.1.1. Market size and forecast, by region, 2016-2026
5.1.2. Comparative market share analysis, 2018 & 2026

5.2. Pharmacy

5.2.1. Market size and forecast, by region, 2016-2026
5.2.2. Comparative market share analysis, 2018 & 2026

5.3. Hospital

5.3.1. Market size and forecast, by region, 2016-2026
5.3.2. Comparative market share analysis, 2018 & 2026

5.4. Others

5.4.1. Market size and forecast, by region, 2016-2026
5.4.2. Comparative market share analysis, 2018 & 2026

6. Tubeless Insulin Pump Market, by Region

6.1. North America

6.1.1. Market size and forecast, by component, 2016-2026
6.1.2. Market size and forecast, by distribution channel, 2016-2026
6.1.3. Market size and forecast, by country, 2016-2026
6.1.4. Comparative market share analysis, 2018 & 2026

6.1.5. U.S.

6.1.5.1. Market size and forecast, by component, 2016-2026
6.1.5.2. Market size and forecast, by distribution channel, 2016-2026
6.1.5.3. Comparative market share analysis, 2018 & 2026

6.1.6. Canada

6.1.6.1. Market size and forecast, by component, 2016-2026
6.1.6.2. Market size and forecast, by distribution channel, 2016-2026
6.1.6.3. Comparative market share analysis, 2018 & 2026

6.1.7. Mexico

6.1.7.1. Market size and forecast, by component, 2016-2026
6.1.7.2. Market size and forecast, by distribution channel, 2016-2026
6.1.7.3. Comparative market share analysis, 2018 & 2026

6.2. Europe

6.2.1. Market size and forecast, by component, 2016-2026
6.2.2. Market size and forecast, by distribution channel, 2016-2026
6.2.3. Market size and forecast, by country, 2016-2026
6.2.4. Comparative market share analysis, 2018 & 2026

6.2.5. Germany

6.2.5.1. Market size and forecast, by component, 2016-2026
6.2.5.2. Market size and forecast, by distribution channel, 2016-2026
6.2.5.3. Comparative market share analysis, 2018 & 2026

6.2.6. France

6.2.6.1. Market size and forecast, by component, 2016-2026
6.2.6.2. Market size and forecast, by distribution channel, 2016-2026
6.2.6.3. Comparative market share analysis, 2018 & 2026

6.2.7. UK

6.2.7.1. Market size and forecast, by component, 2016-2026
6.2.7.2. Market size and forecast, by distribution channel, 2016-2026
6.2.7.3. Comparative market share analysis, 2018 & 2026

6.2.8. Italy

6.2.8.1. Market size and forecast, by component, 2016-2026
6.2.8.2. Market size and forecast, by distribution channel, 2016-2026
6.2.8.3. Comparative market share analysis, 2018 & 2026

6.2.9. Spain

6.2.9.1. Market size and forecast, by component, 2016-2026
6.2.9.2. Market size and forecast, by distribution channel, 2016-2026
6.2.9.3. Comparative market share analysis, 2018 & 2026

6.2.10. Russia

6.2.10.1. Market size and forecast, by component, 2016-2026
6.2.10.2. Market size and forecast, by distribution channel, 2016-2026
6.2.10.3. Comparative market share analysis, 2018 & 2026

6.2.11. Rest of Europe

6.2.11.1. Market size and forecast, by component, 2016-2026
6.2.11.2. Market size and forecast, by distribution channel, 2016-2026
6.2.11.3. Comparative market share analysis, 2018 & 2026

6.3. Asia-Pacific

6.3.1. Market size and forecast, by component, 2016-2026
6.3.2. Market size and forecast, by distribution channel, 2016-2026
6.3.3. Market size and forecast, by country, 2016-2026
6.3.4. Comparative market share analysis, 2018 & 2026

6.3.5. China

6.3.5.1. Market size and forecast, by component, 2016-2026
6.3.5.2. Market size and forecast, by distribution channel, 2016-2026
6.3.5.3. Comparative market share analysis, 2018 & 2026

6.3.6. Japan

6.3.6.1. Market size and forecast, by component, 2016-2026
6.3.6.2. Market size and forecast, by distribution channel, 2016-2026
6.3.6.3. Comparative market share analysis, 2018 & 2026

6.3.7. India

6.3.7.1. Market size and forecast, by component, 2016-2026
6.3.7.2. Market size and forecast, by distribution channel, 2016-2026
6.3.7.3. Comparative market share analysis, 2018 & 2026

6.3.8. South Korea

6.3.8.1. Market size and forecast, by component, 2016-2026
6.3.8.2. Market size and forecast, by distribution channel, 2016-2026
6.3.8.3. Comparative market share analysis, 2018 & 2026

6.3.9. Australia

6.3.9.1. Market size and forecast, by component, 2016-2026
6.3.9.2. Market size and forecast, by distribution channel, 2016-2026
6.3.9.3. Comparative market share analysis, 2018 & 2026

6.3.10. Rest of Asia-Pacific

6.3.10.1. Market size and forecast, by component, 2016-2026
6.3.10.2. Market size and forecast, by distribution channel, 2016-2026
6.3.10.3. Comparative market share analysis, 2018 & 2026

6.4. LAMEA

6.4.1. Market size and forecast, by component, 2016-2026
6.4.2. Market size and forecast, by distribution channel, 2016-2026
6.4.3. Market size and forecast, by country, 2016-2026
6.4.4. Comparative market share analysis, 2018 & 2026

6.4.5. Brazil

6.4.5.1. Market size and forecast, by component, 2016-2026
6.4.5.2. Market size and forecast, by distribution channel, 2016-2026
6.4.5.3. Comparative market share analysis, 2018 & 2026

6.4.6. Saudi Arabia

6.4.6.1. Market size and forecast, by component, 2016-2026
6.4.6.2. Market size and forecast, by distribution channel, 2016-2026
6.4.6.3. Comparative market share analysis, 2018 & 2026

6.4.7. South Africa

6.4.7.1. Market size and forecast, by component, 2016-2026
6.4.7.2. Market size and forecast, by distribution channel, 2016-2026
6.4.7.3. Comparative market share analysis, 2018 & 2026

6.4.8. Rest of LAMEA

6.4.8.1. Market size and forecast, by component, 2016-2026
6.4.8.2. Market size and forecast, by distribution channel, 2016-2026
6.4.8.3. Comparative market share analysis, 2018 & 2026

7. Company profiles

7.1. Medtrum Technologies Inc

7.1.1. Business overview
7.1.2. Financial performance
7.1.3. Product portfolio
7.1.4. Recent strategic moves & developments
7.1.5. SWOT analysis

7.2. Insulet Corporation

7.2.1. Business overview
7.2.2. Financial performance
7.2.3. Product portfolio
7.2.4. Recent strategic moves & developments
7.2.5. SWOT analysis

7.3. Debiotic

7.3.1. Business overview
7.3.2. Financial performance
7.3.3. Product portfolio
7.3.4. Recent strategic moves & developments
7.3.5. SWOT analysis

7.4. Johnson & Johnson

7.4.1. Business overview
7.4.2. Financial performance
7.4.3. Product portfolio
7.4.4. Recent strategic moves & developments
7.4.5. SWOT analysis

7.5. Rosh Holding AG

7.5.1. Business overview
7.5.2. Financial performance
7.5.3. Product portfolio
7.5.4. Recent strategic moves & developments
7.5.5. SWOT analysis

7.6. Cellnovo Group SA

7.6.1. Business overview
7.6.2. Financial performance
7.6.3. Product portfolio
7.6.4. Recent strategic moves & developments
7.6.5. SWOT analysis

7.7. Spring Health Solution Ltd

7.7.1. Business overview
7.7.2. Financial performance
7.7.3. Product portfolio
7.7.4. Recent strategic moves & developments
7.7.5. SWOT analysis

7.8. Veleritas

7.8.1. Business overview
7.8.2. Financial performance
7.8.3. Product portfolio
7.8.4. Recent strategic moves & developments
7.8.5. SWOT analysis

7.9. CeQur SA

7.9.1. Business overview
7.9.2. Financial performance
7.9.3. Product portfolio
7.9.4. Recent strategic moves & developments
7.9.5. SWOT analysis

7.10. Abbott Diabetes Care

7.10.1. Business overview
7.10.2. Financial performance
7.10.3. Product portfolio
7.10.4. Recent strategic moves & developments
7.10.5. SWOT analysis

* Taxes/Fees, If applicable will be added during checkout. All prices in USD.